Trial Details
WITHDRAWNBasic Information
| Clinical ID | c2996 |
|---|---|
| Identifier | NCT02677350 |
| Trial Title | AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Fistulizing Crohn's Disease|Stem Cells |
| Interventions | DRUG: Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs) |
Participant Information
| Sponsor | Joshua M Hare |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2019-12-01 |
|---|---|
| Primary Completion Date | 2025-12 |
| Completion Date | 2026-12 |